Target Prioritization

Inside Stanford's Virtual Biotech: 37,000 AI Agents and the Three Discovery Tasks They Performed

Stanford Medicine researchers have developed a "virtual biotech" company composed of 37,000 AI agents, demonstrating its capability to perform three critical early-stage drug discovery tasks: target prioritization, cancer target validation, and analysis of failed clinical trials.